Drug archive
Cyclosporine (Systemic)Additional Information
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Additional Information
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although not specifically included in the product labeling, cyclosporine is used in certain patients with the following medical conditions:
- Bone marrow transplantation
- Nephrotic syndrome
For patients receiving bone marrow transplantation, cyclosporine may work by preventing the cells from the transplanted bone marrow from attacking the cells of the patient's own body.
The doses of cyclosporine for patients receiving bone marrow transplantation and for patients with nephrotic syndrome are based on the patients" body weight. The usual starting dose for patients receiving bone marrow transplantation is 12.5 milligrams (mg) per kilogram (kg) (5.7 mg per pound) of body weight a day. The dose of cyclosporine for patients with nephrotic syndrome is 3.5 to 5 mg per kg (1.6 to 2.3 mg per pound) of body weight a day.
The side effects that patients experience when they receive cyclosporine for bone marrow transplantation or nephrotic syndrome are similar to those side effects experienced by patients receiving cyclosporine for organ transplantation.
Other than the above information, there is no additional information relating to proper use, precautions, or side effects for these uses.